Recent publications by BIO Center affiliates
- Roby KF, Niu F, Rajewski RA, Decedue C, Subramaniam B, Terranova PF. Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax. Adv Exp Med Biol. 2008; 622: 169-81. Review. PMID: 18546627.
- Shrestha A, Li R, Sil D, Pardeshi NN, Schwarting N, Schorno KS, Rajewski RA, Datta A, David SA. Pharmacokinetics of DS-96, an alkylpolyamine lipopolysaccharide sequestrant, in rodents. J Pharm Sci. 2008 Dec; 97(12): 5376-85. PMID: 18383338.
- Duerfeldt AS, Blagg BS. Hydrating for resistance to radicicol. ACS Chem Biol. 2009 Apr 17; 4 (4): 245-7. Review. PMID: 19371133.
- Amolins MW, Blagg BS. Natural product inhibitors of Hsp90: potential leads fordrug discovery. Mini Rev Med Chem. 2009 Feb; 9(2): 140-52. Review. PMID: 19200020; PMCID: PMC2659174.
- Donnelly A, Blagg BS. Novobiocin and additional inhibitors of the Hsp90Cterminal nucleotide-binding pocket. Curr Med Chem. 2008; 15(26): 2702-17. Review. PMID: 18991631.
- Hadden MK, Blagg BS. Dimeric approaches to anti-cancer chemotherapeutics. Anticancer Agents Med Chem. 2008 Oct; 8(7): 807-16. Review. PMID: 18855582; PMCID: PMC2679389.
- Tongiani S, Ozeki T, Stella VJ. Sulfobutyl ether-alkyl ether mixed cyclodextrin derivatives with enhanced inclusion ability. J Pharm Sci. 2009 Apr 30. [Epub ahead of print] PMID: 19408308.
- Donnelly AC, Mays JR, Burlison JA, Nelson JT, Vielhauer G, Holzbeierlein J, Blagg BS. The design, synthesis, and evaluation of coumarin ring derivatives of the novobiocin scaffold that exhibit antiproliferative activity. J Org Chem. 2008 Nov 21; 73(22): 8901-20. Epub 2008 Oct 22. PMID: 18939877; PMCID: PMC2646372.
- Chittasupho C, Xie SX, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. Eur J Pharm Sci. 2009 May 12; 37(2): 141-50. Epub 2009 Feb 27. PMID: 19429421.
- El-Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm Res. 2009 Jul; 26(7): 1752-63. Epub 2009 May 5. PMID: 19415471.
- Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev. 2009 Jun 21; 61(6): 457-66. Epub 2009 Apr 20. PMID: 19386275.
- Plumley C, Gorman EM, El-Gendy N, Bybee CR, Munson EJ, Berkland C. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. Int J Pharm. 2009 Mar 18; 369(1-2): 136-43. Epub 2008 Oct 25. PMID: 19015016.
- Bailey MM, Gorman EM, Munson EJ, Berkland C. Pure insulin nanoparticle agglomerates for pulmonary delivery. Langmuir. 2008 Dec 2; 24(23): 13614-20. PMID: 18959432; PMCID: PMC2649680.
- Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Med Res Rev. 2009 Jan; 29(1):1 96-212. PubMed PMID: 18958847.
- Singh M, Berkland C, Detamore MS. Strategies and applications for incorporating physical and chemical signal gradients in tissue engineering. Tissue Eng Part B Rev. 2008 Dec; 14(4): 341-66. PMID: 18803499.
- Singh M, Morris CP, Ellis RJ, Detamore MS, Berkland C. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Eng Part C Methods. 2008 Dec; 14(4): 299-309. PMID: 18795865.
- Peek LJ, Roberts L, Berkland C. Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins. Langmuir. 2008 Sep 2; 24(17): 9775-83. Epub 2008 Aug 5. PMID: 18680321.
- Huang M, Berkland C. Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation. J Pharm Sci. 2009 Jan; 98(1): 268-80. PMID: 18425807.
- Mudra DR, Borchardt RT. Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism. J Pharm Sci. 2009 Jul 31. [Epub ahead of print] PMID: 19650119.
- Ouyang H, Andersen TE, Chen W, Nofsinger R, Steffansen B, Borchardt RT. A comparison of the effects of p-glycoprotein inhibitors on the blood-brain barrier permeation of cyclic prodrugs of an opioid peptide (DADLE). J Pharm Sci. 2009 Jun; 98(6): 2227-36. PMID: 18855917.
- Ouyang H, Chen W, Andersen TE, Steffansen B, Borchardt RT. Factors that restrict intestinal cell permeation of cyclic prodrugs of an opioid peptide (DADLE): Part II. Role of metabolic enzymes in the intestinal mucosa. J Pharm Sci. 2009 Jan; 98(1): 349-61. PMID: 18537150.
- Ouyang H, Chen W, Andersen TE, Steffansen B, Borchardt RT. Factors that restrict the intestinal cell permeation of cyclic prodrugs of an opioid peptide(DADLE): Part I. Role of efflux transporters in the intestinal mucosa. J Pharm Sci. 2009 Jan; 98(1): 337-48. PMID: 18537149.
- Burlison JA, Avila C, Vielhauer G, Lubbers DJ, Holzbeierlein J, Blagg BS., Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines. J Org Chem. 2008 Mar 21; 73(6): 2130-7. Epub 2008 Feb 23. PMID: 18293999
- Tash JS, Chakrasali R, Jakkaraj SR, Hughes J, Smith SK, Hornbaker K, Heckert LL, Ozturk SB, Hadden MK, Kinzy TG, Blagg BS, Georg GI., Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and stimulates Il1a transcription in rat sertoli cells. Biol Reprod. 2008 Jun; 78(6): 1139-52. Epub 2008 Jan 23. PMID: 18218611
- Roby KF, Niu F, Rajewski RA, Decedue C, Subramaniam B, Terranova PF., Syngeneic mouse model of epithelial ovarian cancer: effects of nanoparticulate paclitaxel, Nanotax. Adv Exp Med Biol. 2008; 622: 169-81. Review. PMID: 18546627
- Shrestha A, Li R, Sil D, Pardeshi NN, Schwarting N, Schorno KS, Rajewski RA, Datta A, David SA., Pharmacokinetics of DS-96, an alkylpolyamine lipopolysaccharide sequestrant, in rodents. J Pharm Sci. 2008 Mar 27. PMID: 18383338
- Zhang N, Chittasupho C, Duangrat C, Siahaan TJ, Berkland C., PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjug Chem. 2008 Jan; 19(1): 145-52. Epub 2007 Nov 13. PMID: 1799751
- Shi L, Plumley CJ, Berkland C., Biodegradable nanoparticle flocculates for dry powder aerosol formulation. Langmuir. 2007 Oct 23; 23(22): 10897-901. Epub 2007 Sep 26. PMID: 17894513
- Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C., NanoCipro encapsulation in monodisperse large porous PLGA microparticles. J Control Release. 2007 Aug 16; 121(1-2): 100-9. Epub 2007 Jun 13. PMID: 1760487
- Iskandarsyah, Tejo BA, Tambunan US, Verkhivker G, Siahaan TJ., Structural modifications of ICAM-1 cyclic peptides to improve the activity to inhibit heterotypic adhesion of T cells. Chem Biol Drug Des. 2008 Jul; 72(1): 27-33. Epub 2008 Jun 11. PMID: 18554252
- Zheng K, Middaugh CR, Siahaan TJ., Evaluation of the physical stability of the EC5 domain of E-cadherin: Effects of pH, temperature, ionic strength, and disulfide bonds. J Pharm Sci. 2008 Apr 21. PMID: 1842879
- Zimmerman T, Oyarzabal J, Sebastián ES, Majumdar S, Tejo BA, Siahaan TJ, Blanco FJ., ICAM-1 peptide inhibitors of T-cell adhesion bind to the allosteric site of LFA-1. An NMR characterization. Chem Biol Drug Des. 2007 Oct; 70(4): 347- 53. Epub 2007 Sep 14. PMID: 1786807
- Yusuf-Makagiansar H, Yakovleva TV, Tejo BA, Jones K, Hu Y, Verkhivker GM, Audus KL, Siahaan TJ., Sequence recognition of alpha-LFA-1-derived peptides by ICAM-1 cell receptors: inhibitors of T-cell adhesion. Chem Biol Drug Des. 2007 Sep; 70(3) :237-46. PMID: 17718718
- Murray JS, Oney S, Page JE, Kratochvil-Stava A, Hu Y, Makagiansar IT, Brown JC, Kobayashi N, Siahaan TJ., Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation. Chem Biol Drug Des. 2007 Sep; 70(3): 227-36. PMID: 17718717
- Majumdar S, Kobayashi N, Krise JP, Siahaan TJ., Mechanism of internalization of an ICAM-1-derived peptide by human leukemic cell line HL-60: influence of physicochemical properties on targeted drug delivery. Mol Pharm. 2007 Sep-Oct; 4(5): 749-58. Epub 2007 Aug 7. PMID: 1768071
- Kobayashi N, Kobayashi H, Gu L, Malefyt T, Siahaan TJ., Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor. J Pharmacol Exp Ther. 2007 Aug; 322(2) :879-86. Epub 2007 May 23. PMID: 17522343
- Sharov VS, Dremina ES, Pennington J, Killmer J, Asmus C, Thorson M, Hong SJ, Li X, Stobaugh JF, Schöneich C., Selective fluorogenic derivatization of 3- nitrotyrosine and 3,4-dihydroxyphenylalanine in peptides: a method designed for quantitative proteomic analysis. Methods Enzymol. 2008;441:19-32. PMID: 18554527